The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Anthropic has announced two new AI models that it claims represent a major step toward making AI agents truly useful.

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

The Trump administration revoked Harvard University’s ability to enroll international students in its escalating battle with the Ivy League school, saying thousands of current students must transfer t ...

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all ...